Linganisha mbinu

	Uchambuzi wa Tofauti wa eQTL	Uchambuzi wa Utekelezaji Tofauti wa RNA-seq
Nyanja	Bioinformatiki	Bioinformatiki
Familia	Process / pipeline	Process / pipeline
Mwaka wa asili	2007–2012	2008–2010 (RNA-seq DE methodology established)
Mwanzilishi	Pioneered by GTEx Consortium and Stranger et al.; formal differential testing approaches developed ~2007–2012	Multiple groups; foundational methods from Anders & Huber (DESeq, 2010), Robinson, McCarthy & Smyth (edgeR, 2010)
Aina	Statistical genomics pipeline	Quantitative genomics pipeline
Chanzo asilia	Stranger, B. E., et al. (2007). Relative impact of nucleotide and copy number variation on gene expression phenotypes. Science, 315(5813), 848–853.	Love, M. I., Huber, W., & Anders, S. (2014). Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biology, 15(12), 550.
Majina mbadala	deQTL analysis, context-specific eQTL, interaction eQTL, conditional eQTL	RNA-seq DE analysis, transcriptomic differential expression, bulk RNA-seq DE, DEA
Zinazohusiana	6	6
Muhtasari	Differential eQTL analysis identifies genetic variants — expression quantitative trait loci — whose regulatory effect on gene expression varies systematically across biological conditions such as tissue types, disease states, developmental stages, or treatment groups. By testing for statistical interactions between genotype and condition, the method pinpoints loci where the same allele has different transcriptional consequences depending on context, revealing the molecular basis of condition-specific gene regulation.	RNA-seq differential expression (DE) analysis identifies genes whose transcript abundance differs significantly between two or more biological conditions — for example, treated versus control, or diseased versus healthy tissue. Starting from raw sequencing reads, the pipeline moves through alignment, count-based normalization, statistical modeling of count dispersion, hypothesis testing, and multiple-testing correction to produce a ranked list of differentially expressed genes accompanied by fold-change estimates and adjusted p-values.